Status:
RECRUITING
LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions
Lead Sponsor:
Federico II University
Collaborating Sponsors:
Azienda Sanitaria Locale Napoli 2 Nord
Conditions:
Long Covid-19
Eligibility:
All Genders
18+ years
Brief Summary
Considering the compelling amount of studies focused on patients in the active phase of COVID-19 disease and the scarcity of studies focused on patient cured from disease aimed at evaluating the seque...
Detailed Description
The aim of the study is to investigate whether in patients recovered from COVID-19 disease, SARS-CoV-2 infection has induced: 1) Endocrine-metabolic function damage, 2) Neuro-psychiatric damage, 3) Mu...
Eligibility Criteria
Inclusion
- Patients of both sexes recovered from SARS-CoV-2 infection (two negative nasopharyngeal swabs, negative IgM and positive anti SARS-CoV-2 IgG);
- Aged over 18 years of age;
- Ability to understand protocol procedures
Exclusion
- Any psychological/psychiatric/other medical conditions compromising the understanding of the nature and purpose of the study, and of its possible consequences
- uncooperative attitude of the patient
Key Trial Info
Start Date :
January 27 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 27 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05293366
Start Date
January 27 2022
End Date
January 27 2027
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federico II University of Naples
Naples, Italy, 80131